GENB · Generate Biomedicines, Inc. · Financials
$13.92
+0.23 (+1.68%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 6, 2026
The latest filing states the doubt was alleviated.
“As of December 31, 2025, the Company had concluded that there was substantial doubt about its ability to continue as a going concern. Upon closing of the IPO and receipt of the associated cash proceeds, the Company has alleviated the substantial doubt that previously existed, and based on the Company’s current capital resources, which consists of its cash, cash equivalents and marketable securities on hand at June 30, 2026, it expects to have sufficient cash to fund our current operating plan into the first half of 2028.”View the 10-Q filed Aug 6, 2026
Market Cap
$1.94B
Shares
128.35M
Volume · Oct 5
1.12M
Avg daily vol (3M)
1.03M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
No structured figures reported for this view yet.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current finance lease liabilities | 2026-06-30 | USD 3,744,000 | 10-Q filed 2026-08-06 |
| Current operating lease liabilities | 2026-06-30 | USD 9,875,000 | 10-Q filed 2026-08-06 |
| Noncurrent finance lease liabilities | 2026-06-30 | USD 1,366,000 | 10-Q filed 2026-08-06 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 47,643,000 | 10-Q filed 2026-08-06 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.